GammaDelta grabs seed funds

UK-based GammaDelta Therapeutics Ltd, an immunotherapy company, has secured an undisclosed amount of seed funding. The investor was Abingworth.

16 September 2016•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.